AbbVie Inc. 8-K Summary: Annual Meeting Results
Business Context and Reporting Period
This Form 8-K reports the results of AbbVie Inc.'s Annual Meeting of Stockholders held on May 8, 2015. The filing details the outcomes of three specific matters submitted to a vote by security holders.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This document is a current report regarding corporate governance events rather than a financial statement.
Material Changes and Voting Results
The following matters were voted upon and approved by stockholders:
- Election of Class III Directors: Three directors were elected with terms expiring in 2018.
- Roxanne S. Austin: 1,016,745,497 votes For; 118,346,407 votes Withheld.
- Richard A. Gonzalez: 1,085,992,401 votes For; 49,099,503 votes Withheld.
- Glenn F. Tilton: 1,114,111,201 votes For; 20,980,703 votes Withheld.
- Ratification of Independent Auditor: Stockholders ratified the appointment of Ernst & Young LLP as the independent registered public accounting firm for 2015.
- For: 1,331,520,648
- Against: 30,658,983
- Abstain: 2,917,292
- Advisory Vote on Executive Compensation: Stockholders approved the compensation of named executive officers on an advisory basis.
- For: 1,075,816,444
- Against: 51,054,382
- Abstain: 8,221,078
Guidance, Outlook, and Risks
The filing text does not provide a clear value for guidance, outlook, management commentary, risks, contingencies, or unusual items. The document is limited to the tabulation of votes.
Investor Verification Checklist
- Verify the terms of the newly elected Class III Directors (expiring 2018).
- Confirm the engagement of Ernst & Young LLP for the 2015 fiscal year.
- Note the significant number of Broker Non-Votes (230,005,019) on the director election and executive compensation proposals.
- Review the full Proxy Statement for detailed biographies of directors and executive compensation specifics.